Calidi Biotherapeutics, Inc. — 10-Q Filings
13 10-Q filings on record
This page lists all 10-Q filings submitted to the SEC by Calidi Biotherapeutics, Inc. (CLDWW), sorted by most recent first. Each row links to the full filing on EdgarLookup. Calidi Biotherapeutics, Inc. has filed 13 10-Q documents with the SEC since 2021. To view all SEC filings by Calidi Biotherapeutics, Inc., see the full filings list.
All
10-K
10-Q
25
25-NSE
3
3/A
4
424B3
424B4
424B5
425
8-A12B
8-K
8-K/A
CERT
CORRESP
D
DEF 14A
DEFA14A
DRS
DRS/A
EFFECT
NT 10-Q
PRE 14A
S-1
S-1/A
S-3
S-3/A
S-3MEF
S-4
S-4/A
S-8
SC 13D
SC 13D/A
SC 13G
SC 13G/A
SCHEDULE 13D
SCHEDULE 13G
SCHEDULE 13G/A
SEC STAFF LETTER
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| 10-Q | 10-Q | 0001493152-25-022372 | Nov 13, 2025 | Sep 30, 2025 |
| 10-Q | 10-Q | 0001641172-25-022797 | Aug 8, 2025 | Jun 30, 2025 |
| 10-Q | 10-Q | 0001641172-25-010317 | May 14, 2025 | Mar 31, 2025 |
| 10-Q | — | 0001493152-24-044833 | Nov 12, 2024 | Sep 30, 2024 |
| 10-Q | — | 0001493152-24-031688 | Aug 13, 2024 | Jun 30, 2024 |
| 10-Q | — | 0001493152-24-019305 | May 14, 2024 | Mar 31, 2024 |
| 10-Q | — | 0001493152-23-041122 | Nov 14, 2023 | Sep 30, 2023 |
| 10-Q | 10-Q | 0001193125-23-217072 | Aug 21, 2023 | Jun 30, 2023 |
| 10-Q | 10-Q | 0001193125-23-145095 | May 15, 2023 | Mar 31, 2023 |
| 10-Q | 10-Q | 0001193125-22-282874 | Nov 14, 2022 | Sep 30, 2022 |
| 10-Q | 10-Q | 0001193125-22-216531 | Aug 10, 2022 | Jun 30, 2022 |
| 10-Q | 10-Q | 0001193125-22-146662 | May 11, 2022 | Mar 31, 2022 |
| 10-Q | FORM 10-Q | 0001193125-21-328181 | Nov 12, 2021 | Sep 30, 2021 |